Active	Status	Sponsor type	Region	Phase	Filter
6 Active 6 Inactive 12 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Withrow, Kirk
OSPREY, NCT04950894: Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Neurostimulation	Active, not recruiting	N/A	150	US	Hypoglossal Nerve Stimulation	LivaNova	Obstructive Sleep Apnea, OSA, Apnea, Apnea, Obstructive, Apnea, Obstructive Sleep, Apnea+Hypopnea, Hypopnea, Sleep	10/24	04/25
NCT02907398: Adherence and Outcome of Upper Airway Stimulation (UAS) for OSA International Registry	Active, not recruiting	N/A	5000	Europe, US	Inspire therapy, ADHERE, No intervention, CONTROL	Inspire Medical Systems, Inc.	Obstructive Sleep Apnea	09/25	12/25
Miller, Norma
NCT04511078: Phase II Panitumumab-IRDye800 in Head & Neck Cancer	Recruiting	2	25	US	Panitumumab-IRDye800, panitumumab-IRDye800CW	University of Alabama at Birmingham	Head and Neck Cancer	12/26	12/27
NCT03439865: Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis	Recruiting	1	20	US	Ivacaftor, Kalydeco, standard of care treatment	University of Alabama at Birmingham, National Heart, Lung, and Blood Institute (NHLBI)	Chronic Rhinosinusitis (Diagnosis)	12/24	05/25
NCT01017055: Voice and Swallowing Outcomes Following Revision Anterior Cervical Spine Surgery	Recruiting	N/A	200	US	Voice and Swallowing evaluations	University of Alabama at Birmingham	Dysphagia, Dysphonia	12/24	06/25
NCT02038166: Nasal Potential Difference (NPD) Protocol in Chronic Rhinosinusitis	Recruiting	N/A	20	US		University of Alabama at Birmingham, National Heart, Lung, and Blood Institute (NHLBI)	Rhinosinusitis	12/24	12/26